Dr. Lewis Teperman of New York is a highly regarded liver transplant surgeon and has garnered awards and widespread recognition for his expertise in the field. Dr. Teperman is the Director of Transplantation at NYU Langone Medical Center, which does cutting-edge research on transplant technologies, including artificial organs for liver patients.

1. ELAD - A Breakthrough in
Artificial Organ Technology
By Dr. Lewis Teperman

2. Introduction
 Dr. Lewis Teperman of New York is a
highly regarded liver transplant
surgeon and has garnered awards
and widespread recognition for his
expertise in the field. Dr. Teperman is
the Director of Transplantation at NYU
Langone Medical Center, which does
cutting-edge research on transplant
technologies, including artificial organs
for liver patients.

3. About Extracorporeal Liver Assist
Device
 The Extracorporeal Liver Assist Device or
ELAD is a bedside system that performs the
functions of a real liver by metabolizing toxins
in the blood plasma and synthesizing
proteins. ELAD consists of canisters that
contain human liver cells and functions
somewhat like a dialysis machine. It can help
extend the lives patients who are suffering
from acute liver failure as they wait for a liver
transplant by providing the necessary
metabolic support. Depending on the severity
of the liver disease, it might even be able to
relieve some of the burden on the patient's
own liver, thus giving it an opportunity to
regenerate and recover some of its original
functionality.

4. Conclusion
 Dr. Lewis Teperman and his team
have conducted research on the
safety and efficacy of the ELAD
support system in patients with acute
or chronic liver failure, as well as
acute alcoholic hepatitis.